Medicure (OTCMKTS:MCUJF – Get Free Report) released its quarterly earnings results on Thursday. The company reported $999.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $999.04, Zacks reports. Medicure had a negative return on equity of 17.91% and a negative net margin of 13.10%.
Medicure Price Performance
MCUJF remained flat at $0.96 during trading on Thursday. Medicure has a one year low of $0.60 and a one year high of $0.97. The business has a fifty day moving average price of $0.84 and a two-hundred day moving average price of $0.84. The stock has a market cap of $10.06 million, a P/E ratio of -4.01 and a beta of 1.11. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.44 and a quick ratio of 1.00.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Read More
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
